Veradermics, INC Form 4 insider transactions

Montanova Capital, Llc and 3 others reported changes in beneficial ownership of Veradermics, Inc common stock on August 19, 2026.

Timothy August Durso, Chief Technical Officer of Veradermics, Inc, sold 43,500 shares of common stock on August 17, 2026.

Reid Alexander Waldman, Chief Executive Officer and a Director of Veradermics, Inc, sold 67,500 shares of common stock on August 17, 2026.

John W Childs, a Director of Veradermics, Inc, sold 100,000 shares of common stock on August 12, 2026.

Veradermics, Inc. secures a $30 million investment from Suvretta Capital through a private placement of pre-funded warrants.

Veradermics Director John W. Childs filed an amended Form 4 to correct the nature of indirect beneficial ownership for 294,117 common shares.

Suvretta Capital Management and affiliated funds significantly increased their beneficial ownership in Veradermics, Inc. through open market purchases in early February 2026.